Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06581406 |
| Title | A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma (RP2-202) |
| Acronym | RP2-202 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Replimune Inc. |
| Indications | |
| Therapies | |
| Age Groups: | child | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| HonorHealth Research Insisute | RECRUITING | Scottsdale | Arizona | 85258 | United States | Details |
| Stanford Cancer Institute | RECRUITING | Palo Alto | California | 94304 | United States | Details |
| University of Iowa | RECRUITING | Iowa City | Iowa | 52242 | United States | Details |
| Duke University Medical Center | RECRUITING | Durham | North Carolina | 27710 | United States | Details |
| Thomas Jefferson University | RECRUITING | Philadelphia | Pennsylvania | 19107 | United States | Details |